Gene · 200424
Papers2,594
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,594
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HCMV encoded UL84 hijacks FHL2 to suppress type I interferon production and enhance viral replication. | PLoS Pathog | 2026 | 41587224 | PubTator, text mining | PubMed |
| Biochemical engineering of 5hmdC-DNA using a Tet3 double-mutant. | Comput Struct Biotechnol J | 2026 | 41585936 | PubTator, text mining | PubMed |
| SHP2 promotes osteosarcoma via regulating STAT3/TET3/HOXB2 signaling. | Sci Rep | 2026 | 41580426 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review). | Oncol Rep | 2026 | 41574724 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Comprehensive assessment of activity, specificity, and safety of hypercompact TnpB systems for gene editing. | Genome Biol | 2026 | 41566394 | PubTator, text mining | PubMed |
| The role of cytosine modification symmetry in mammalian epigenome regulation. | Chem Sci | 2026 | 41536432 | PubTator, text mining | PubMed |
| The TET/5hmC mediated epigenetic landscape in glioma: From molecular mechanisms to therapeutic targeting and future perspectives. | Pharmacol Res | 2026 | 41525854 | PubTator, text mining | PubMed |
| TET3-Mediated m5C Modification of CCAT2 Accelerates Cardiac Microvascular Endothelial Cell Damage in Acute Coronary Syndrome. | Kaohsiung J Med Sci | 2026 | 41317007 | PubTator, text mining | PubMed |
| Integration of epigenetics into ecotoxicology: insights and fundamental research needs. | Biol Rev Camb Philos Soc | 2026 | 41242758 | PubTator, text mining | PubMed |
| CRISPR-based Transcriptional Regulation: Technologies, Applications, and Future Directions. | DNA (Basel) | 2025 | 41877893 | PubTator, text mining | PubMed |
| Epigenetic Mechanisms, Assessment and Therapeutics of Epidermal Stem Cells in Skin Aging. | Stem Cells Int | 2025 | 41497803 | PubTator, text mining | PubMed |
| [Analysis of clinical and genetic characteristics in a patient with Beck-Fahrner syndrome due to a frameshift variant of TET3 gene]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2025 | 41451500 | PubTator, text mining | PubMed |
| Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. | Nat Commun | 2025 | 41390755 | PubTator, text mining | PubMed |
| High matrix stiffness triggers the YAP-OPA1-TET1/3 loop to drive chemoresistance via enhanced nuclear-mitochondrial communication. | iScience | 2025 | 41362610 | PubTator, text mining | PubMed |
| Targeting TET3 suppresses group 3 medulloblastoma stemness and progression via impairing hypomethylation of Otx2 super-enhancer. | Cell Rep Med | 2025 | 41338221 | PubTator, text mining | PubMed |
| mRNA expression of DNA methylation machinery genes in periapical granuloma and their potential relationship with periapical wound healing. | Sci Rep | 2025 | 41330979 | PubTator, text mining | PubMed |
| Targeting TET enzymes in ovarian cancer: epigenetic regulation, chemoresistance, and therapeutic opportunities. | Epigenomics | 2025 | 41321016 | PubTator, text mining | PubMed |
| The Role of mRNA Alternative Processing in Mammalian Neurodevelopment. | Int J Mol Sci | 2025 | 41303558 | PubTator, text mining | PubMed |
| Loss of TET2 activity limits the ability of vitamin C to activate DNA demethylation in human HAP1 cells. | Epigenetics Chromatin | 2025 | 41287077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200424/papers?page=3